JP2010510216A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010510216A5 JP2010510216A5 JP2009537209A JP2009537209A JP2010510216A5 JP 2010510216 A5 JP2010510216 A5 JP 2010510216A5 JP 2009537209 A JP2009537209 A JP 2009537209A JP 2009537209 A JP2009537209 A JP 2009537209A JP 2010510216 A5 JP2010510216 A5 JP 2010510216A5
- Authority
- JP
- Japan
- Prior art keywords
- ring
- compound according
- independently
- groups
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 C*C=C(CC1CC(C)(C)C(C(C)C)C(CC(C)=C)C1)*C Chemical compound C*C=C(CC1CC(C)(C)C(C(C)C)C(CC(C)=C)C1)*C 0.000 description 7
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85911306P | 2006-11-15 | 2006-11-15 | |
| US98414907P | 2007-10-31 | 2007-10-31 | |
| PCT/US2007/023999 WO2008060597A2 (en) | 2006-11-15 | 2007-11-15 | Compounds useful as protein kinase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010510216A JP2010510216A (ja) | 2010-04-02 |
| JP2010510216A5 true JP2010510216A5 (enExample) | 2011-12-15 |
Family
ID=39402262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009537209A Pending JP2010510216A (ja) | 2006-11-15 | 2007-11-15 | プロテインキナーゼのインヒビターとして有用な化合物 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US7838517B2 (enExample) |
| EP (1) | EP2094712B1 (enExample) |
| JP (1) | JP2010510216A (enExample) |
| AT (1) | ATE528309T1 (enExample) |
| AU (1) | AU2007319786A1 (enExample) |
| CA (1) | CA2669886A1 (enExample) |
| ES (1) | ES2372320T3 (enExample) |
| MX (1) | MX2009005231A (enExample) |
| NZ (1) | NZ576950A (enExample) |
| WO (1) | WO2008060597A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0620059D0 (en) * | 2006-10-10 | 2006-11-22 | Ucb Sa | Therapeutic agents |
| AU2007319786A1 (en) | 2006-11-15 | 2008-05-22 | Vertex Pharmaceuticals Incorporated | Compounds useful as protein kinase inhibitors |
| WO2011073339A1 (en) * | 2009-12-18 | 2011-06-23 | Janssen Pharmaceutica Nv | Bicyclic thiazoles as allosteric modulators of mglur5 receptors |
| CN102666551B (zh) | 2009-12-18 | 2014-12-10 | 詹森药业有限公司 | 作为mglur5受体的变构调节剂的双环噻唑 |
| ES2706066T3 (es) | 2010-07-02 | 2019-03-27 | Univ Health Network | Procedimiento dirigido a enfermedades mutantes con PTEN y composiciones para las mismas |
| ES2874632T3 (es) | 2016-12-12 | 2021-11-05 | Union Therapeutics As | Pirazoloazepin-8-onas sustituidas y su uso como inhibidores de la fosfodiesterasa |
| JP6850886B2 (ja) | 2016-12-12 | 2021-03-31 | レオ ファーマ アクティーゼルスカブ | 置換ピラゾロアゼピン−４−オンおよびそれらのホスホジエステラーゼ阻害剤としての使用 |
| EP3551632B1 (en) * | 2016-12-12 | 2024-06-12 | UNION therapeutics A/S | Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH632755A5 (de) * | 1976-04-10 | 1982-10-29 | Basf Ag | Verfahren zur herstellung von thiophenverbindungen. |
| US5206240A (en) * | 1989-12-08 | 1993-04-27 | Merck & Co., Inc. | Nitrogen-containing spirocycles |
| WO1993013105A1 (en) | 1991-12-26 | 1993-07-08 | Yoshitomi Pharmaceutical Industries, Ltd. | Condensed thiophene compound and pharmaceutical use thereof |
| ZA200504898B (en) * | 2002-12-20 | 2006-11-29 | Pharmacia Corp | Acyclic pyrazole compounds |
| CA2553670A1 (en) * | 2004-01-29 | 2005-08-11 | Elixir Pharmaceuticals, Inc. | Anti-viral therapeutics |
| GB0508471D0 (en) * | 2005-04-26 | 2005-06-01 | Celltech R&D Ltd | Therapeutic agents |
| AU2007319786A1 (en) | 2006-11-15 | 2008-05-22 | Vertex Pharmaceuticals Incorporated | Compounds useful as protein kinase inhibitors |
-
2007
- 2007-11-15 AU AU2007319786A patent/AU2007319786A1/en not_active Abandoned
- 2007-11-15 MX MX2009005231A patent/MX2009005231A/es active IP Right Grant
- 2007-11-15 AT AT07867462T patent/ATE528309T1/de not_active IP Right Cessation
- 2007-11-15 JP JP2009537209A patent/JP2010510216A/ja active Pending
- 2007-11-15 EP EP07867462A patent/EP2094712B1/en not_active Not-in-force
- 2007-11-15 NZ NZ576950A patent/NZ576950A/en not_active IP Right Cessation
- 2007-11-15 WO PCT/US2007/023999 patent/WO2008060597A2/en not_active Ceased
- 2007-11-15 CA CA002669886A patent/CA2669886A1/en not_active Abandoned
- 2007-11-15 ES ES07867462T patent/ES2372320T3/es active Active
-
2009
- 2009-05-15 US US12/466,420 patent/US7838517B2/en not_active Expired - Fee Related
-
2010
- 2010-10-13 US US12/903,390 patent/US8399458B2/en not_active Expired - Fee Related
-
2013
- 2013-02-13 US US13/765,864 patent/US20130267498A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7416365B2 (ja) | アポトーシス誘発剤 | |
| JP2010510216A5 (enExample) | ||
| JP2010513285A5 (enExample) | ||
| WO2021168193A1 (en) | Pyridopyrimidine derivatives as kras inhibitors | |
| JP2009523822A5 (enExample) | ||
| JP6517928B2 (ja) | キナーゼ阻害剤として有用なインドールカルボキシアミド | |
| JP2010510215A5 (enExample) | ||
| EP4612155A1 (en) | 1,5-naphthyridine derivatives as kras oncoprotein inhibitors | |
| JP2025114615A (ja) | 治療薬としての細胞毒素のペプチドコンジュゲート | |
| KR102346508B1 (ko) | 키나제 억제제로서 유용한 치환된 테트라히드로카르바졸 및 카르바졸 카르복스아미드 화합물 | |
| JP2013010792A5 (enExample) | ||
| CN109790158B (zh) | 作为jak抑制剂杂环化合物，该化合物的盐类及其治疗用途 | |
| JP2020506951A5 (enExample) | ||
| JP2009513703A5 (enExample) | ||
| WO1998029397A1 (en) | Fused pyrimidine compounds and medicinal use thereof | |
| JP2006513208A5 (enExample) | ||
| JP2013506715A5 (enExample) | ||
| MX2010006182A (es) | Derivados de isoxazolo-piridazina. | |
| EA024890B1 (ru) | Имидазопиридазины в качестве ингибиторов akt киназы | |
| KR20160022890A (ko) | 키나제 억제제로서 유용한 카르바졸 카르복스아미드 화합물 | |
| JP2017502092A5 (enExample) | ||
| JP2020503376A5 (enExample) | ||
| JP6913955B2 (ja) | ＰＩ３Ｋ／ｍＴＯＲ阻害剤としての溶融キノリン化合物 | |
| RU2008102155A (ru) | ЗАМЕЩЕННЫЕ 3-СУЛЬФОНИЛ-[1,2,3]ТРИАЗОЛО[1,5-a]ПИРИМИДИНЫ-АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-НТ6 РЕЦЕПТОРОВ, ЛЕКАРСТВЕННАЯ СУБСТАНЦИЯ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ЛЕКАРСТВЕННЫЙ ПРЕПАРАТ И СПОСОБЫ ИХ ПОЛУЧЕНИЯ | |
| RU2009103302A (ru) | Применение производных имидазо[1,2-а]пиридин-2-корбоксамидов в терапии |